Synbio International Inc (SYIN)

[tedpeele]

Lots to build on here:

NHYF has executed one Option agreement and two Memorandums of Understanding to evaluate investment in and/or the further development of the following AI-based medical technology:

• Life-Saving Innovation: AI-based intellectual property for the fast and early identification of life threatening pulmonary embolisms using CAT scan detection software. A pulmonary embolism is a medical emergency; it may be fatal causing death. Pulmonary embolism affects around 900,000 people in the U.S. every year . The AI-powered technology aims to improve the radiologic processing time and reading performance during emergency evaluations.

• Facial Analysis to objectively screen for PTSD: AI-based facial analysis technology to objectively screen for posttraumatic stress disorder. The technology will analyze and interpret facial data, the result of which will be seen immediately by the user – with an option of sending it to their medical practitioner. This innovative approach will empower individuals and their healthcare providers to proactively manage mental health. The incidence of mental illness in the USA is well known; and the cost is estimated at $300Billion annually. A quick and objective assessment of PTSD is required by patients and healthcare professionals alike.

• Evolution in Evaluation and Treatment of Pain Management: A breakthrough new AI program (Chatbot) to simulate conversation with individuals suffering from chronic pain. The program will be designed to immediately address the pain sufferer’s acute and chronic pain and provide viable options to consider as they search for a medical personnel who has the appropriate expertise. It will also create a written dialogue that can be reviewed by medical practitioners and may become an integral part of the pain sufferer’s comprehensive pain management plan.


NHYF's vision extends beyond AI, encompassing innovative nutraceutical solutions. The company is poised to launch an anti-anxiety product - the first of its nutritional supplements that can be added to medical protocols for the longterm management of anxiety. The market for nutraceuticals in the USA has been experiencing robust growth, driven by increasing consumer awareness of the link between diet, health, and wellness. With a growing emphasis on preventive healthcare, the demand for dietary supplements and functional foods that offer potential health benefits beyond basic nutrition continues to expand, creating a dynamic landscape for the Company’s nutraceutical businesses to flourish


..